These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36107725)

  • 1. Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab.
    Jackson EM; Harper S; Webb GJ; Thomas W
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36107725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria.
    Kamura Y; Sakamoto T; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Chiba S; Obara N
    Int J Hematol; 2022 Jul; 116(1):55-59. PubMed ID: 35668275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Immune-Mediated RBC Destruction.
    Jacobs JW; Booth GS
    Am J Clin Pathol; 2022 Jun; 157(6):844-851. PubMed ID: 34919640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
    van Daalen ST; van Dijken PJ; Tamminga RY; Brons PP
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2350-4. PubMed ID: 16261716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe refractory idiopathic warm autoimmune haemolytic anaemia responsive to complement inhibition with eculizumab.
    Neave L; Wilson AJ; Lissack M; Scully M
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe case of refractory immune thrombocytopenic purpura requiring splenectomy after the COVID-19 vaccine.
    Koilpillai S; Dominguez B; Khan A; Carlan S
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35725277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report.
    Garg M; Agarwal S; Altohami M
    Br J Haematol; 2022 Apr; 197(2):e28-e31. PubMed ID: 34993954
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-COV-2 vaccine responses in renal patient populations.
    Smith RM; Cooper DJ; Doffinger R; Stacey H; Al-Mohammad A; Goodfellow I; Baker S; Lear S; Hosmilo M; Pritchard N; Torpey N; Jayne D; Yiu V; Chalisey A; Lee J; Vilnar E; Cheung CK; Jones RB
    BMC Nephrol; 2022 May; 23(1):199. PubMed ID: 35641961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold agglutinin disease after COVID-19 vaccine.
    Aoun SA; Motabi I
    Br J Haematol; 2021 Dec; 195(5):650. PubMed ID: 34176130
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.
    Fattizzo B; Pasquale R; Bellani V; Barcellini W; Kulasekararaj AG
    Front Immunol; 2021; 12():791429. PubMed ID: 34899761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Warm autoimmune hemolytic anemia and IgM-monoclonal gammopathy following BNT162b2 COVID-19 vaccine in a patient with splenic marginal zone lymphoma].
    Sogabe N; Kuno M; Nakagama Y; Makuuchi Y; Harada N; Takakuwa T; Okamura H; Hirose A; Nishimoto M; Nakashima Y; Koh H; Nakamae M; Kido Y; Nakamae H; Hino M
    Rinsho Ketsueki; 2022; 63(10):1379-1385. PubMed ID: 36351643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
    Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H
    J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
    Lutrick K; Rivers P; Yoo YM; Grant L; Hollister J; Jovel K; Khan S; Lowe A; Baccam Z; Hanson H; Olsho LEW; Fowlkes A; Caban-Martinez AJ; Porter C; Yoon S; Meece J; Gaglani M; Burns J; Mayo Lamberte J; Nakayima Miiro F; Bissonnette A; LeClair L; Kutty PK; Romine JK; Stefanski E; Edwards LJ; Ellingson K; Gerald JK; Bedrick EJ; Madhivanan P; Krupp K; Gerald LB; Thompson M; Burgess JL
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1761-1765. PubMed ID: 34968373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
    Valent P; Lechner K
    Wien Klin Wochenschr; 2008; 120(5-6):136-51. PubMed ID: 18365153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine.
    Gadi SRV; Brunker PAR; Al-Samkari H; Sykes DB; Saff RR; Lo J; Bendapudi P; Leaf DE; Leaf RK
    Transfusion; 2021 Nov; 61(11):3267-3271. PubMed ID: 34549821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.
    Sormani MP; Inglese M; Schiavetti I; Carmisciano L; Laroni A; Lapucci C; Da Rin G; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
    EBioMedicine; 2021 Oct; 72():103581. PubMed ID: 34563483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine.
    Piotrowska M; Zieliński M; Tylicki L; Biedunkiewicz B; Kubanek A; Ślizień Z; Polewska K; Tylicki P; Muchlado M; Sakowska J; Renke M; Sudoł A; Dąbrowska M; Lichodziejewska-Niemierko M; Smiatacz T; Dębska-Ślizień A; Trzonkowski P
    Front Immunol; 2022; 13():832924. PubMed ID: 35935974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
    Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K
    Front Immunol; 2021; 12():704773. PubMed ID: 34220867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.